1例肾移植术后他克莫司致严重腹泻及便血的罕见不良反应分析OA
A Rare Adverse Reaction Analysis of Severe Diarrhea and Bloody Stools Induced by Tacrolimus After Kidney Transplantation:A Case Report
目的:报告1例肾移植术后患者使用他克莫司后出现严重腹泻伴便血的罕见不良反应,为免疫抑制剂的安全合理使用提供参考.方法:对肾移植术后患者在服用他克莫司期间出现的严重腹泻和便血进行药学干预和回顾性分析,结合文献评估关联性并探讨其发病机制.结果:基于临床表现及不良反应关联性评价,判定他克莫司与患者严重腹泻伴便血症状"很可能有关".他克莫司可能改变血管通透性,导致肠黏膜缺血性损伤和继发感染.结论:他克莫司虽为常用的免疫抑制剂,但个别患者可能发生严重的胃肠道不良反应.临床应高度警惕,及时识别并调整免疫治疗方案.
Objective:To report a case of severe diarrhea with hematochezia as a rare adverse reaction in a post-kidney transplantation patient taking tacrolimus,and to provide a reference for the safe and rational use of immunosuppressants.Methods:Pharmaceutical intervention and retrospective analysis were conducted for the post-kidney transplantation patient who developed severe diarrhea with bloody stools while taking tacrolimus.The correlation was assessed and pathogenesis was explored based on literature review.Results:Based on clinical manifestations and adverse reaction correlation assessment,it was determined that tacrolimus was"highly probable"to be associated with the patient's severe diarrhea with bloody stools.Tacrolimus may alter vascular permeability,leading to ischemic injury of the intestinal mucosa and secondary infection.Conclusion:Although tacrolimus is a commonly used immunosuppressant,some patients may experience severe gastrointestinal adverse reactions.Clinicians should remain highly vigilant,identify these reactions promptly,and adjust immunosuppressive regimens accordingly.
贾国舒;齐文昕;刘鑫;刘珣;李慧博
北京大学第三医院药学部,北京 100191||北京大学药学院药事管理与临床药学系,北京 100191北京大学第三医院消化科,北京 100191北京大学第三医院消化科,北京 100191北京大学第三医院消化科,北京 100191北京大学第三医院药学部,北京 100191
医药卫生
他克莫司腹泻便血药品不良反应肾移植术后
tacrolimusdiarrheabloody stoolsadverse drug reactionspost-kidney transplantation
《中国合理用药探索》 2026 (2)
26-31,6
评论